GeriScan Geriatric Consulting

A 2005 American Geriatrics Society report noted that, for every
5,000 Americans age 65 and older, there is only one geriatrician.

PHARMACEUTICAL REPRESENTATIVES

LEGAL DISCLAIMER

GeriScan Geriatric Consulting
PO Box 777
Clarks Summit, PA 18411
570.586.0655

"In the United States today, 13%, or approximately 35 million of our population, is aged 65 and older. In
   just seven years, the "baby boomers" will begin turning 65. Ten thousand "boomers" per day will reach
   this milestone over the next 20 years. By 2030, the number of people aged 65 and older will have
   doubled, swelling to 71 million. One in five Americans will be 65 and older. The fastest-growing segment,
   and the segment of the population that will place the greatest demand on the healthcare system, those
   ages 85 and older, will rise in number from 4 million to 20 million by mid-century. The number of
   centenarians in the U.S. population will soar to more than 800,000 by 2050."

-- The American Geriatrics Society, February, 2005

You want to move product. Caregivers want to ensure they are buying the right product and using it properly. Both you and your customers can benefit from an educational presentation by Susan Scanland, owner of GeriScan.

With nearly 25 years of experience specific to geriatrics, Susan knows what your customers want - and what their patients need. The fact that approximately 10% of elders receive optimal treatment of depression and Alzheimer's leaves a huge untapped market share. Susan has the unique ability to relate to all levels of nursing care, having worked in geriatric settings as a CNA, staff nurse, and nurse practitioner, along with formally educating physicians for 12 years and nurse practitioners for four years. Susan takes the latest evidence-based geriatric research and targets that information in ways to which every participant can relate.

Wouldn't you like to experience the benefits of a GeriScan presentation?

Learn more about available programs

- Pharmacoeconomics of Alzheimer's Treatment

- Pharmacoeconomics of Treating Depression in Elders

- Costs of Suboptimal Alzheimer's Treatment to Caregivers

- Can the Quality Indicators be Improved with Cholinesterase Inhibitors and Memantine?

- Consultant Pharmacists' Dilemmas in LTC: A Discussion

NOTE: For programs of interest to the primary care pharmaceutical representative, please see the nurse practitioner/PA/primary care physician page. For programs of interest to long-term care pharmaceutical representatives, please see the LTC/ALF nurse page.

Click here to email Susan Scanland about customized programs and inquire about availability.